The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy

BACKGROUND: Preoperative/neoadjuvant therapy (NT) is increasingly utilized for the treatment of pancreas cancer (PDAC). However, little data exist regarding to inform the use of additional postoperative therapy following NT. The lymph node ratio (LNR) is a prognostic marker of oncologic outcomes aft...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Surg Oncol
Autori principali: Roland, Christina L., Katz, Matthew H. G., Tzeng, Ching-Wei D., Lin, Heather, Varadhachary, Gauri R., Shroff, Rachna, Javle, Milind, Fogelman, David, Wolff, Robert A., Vauthey, Jean N., Crane, Christopher H., Lee, Jeffrey E., Fleming, Jason B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5192562/
https://ncbi.nlm.nih.gov/pubmed/26350371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4854-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi